Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 16 (3), 149-63

Harnessing the Plasticity of CD4(+) T Cells to Treat Immune-Mediated Disease

Affiliations
Review

Harnessing the Plasticity of CD4(+) T Cells to Treat Immune-Mediated Disease

Michel DuPage et al. Nat Rev Immunol.

Abstract

CD4(+) T cells differentiate and acquire distinct functions to combat specific pathogens but can also adapt their functions in response to changing circumstances. Although this phenotypic plasticity can be potentially deleterious, driving immune pathology, it also provides important benefits that have led to its evolutionary preservation. Here, we review CD4(+) T cell plasticity by examining the molecular mechanisms that regulate it - from the extracellular cues that initiate and drive cells towards varying phenotypes, to the cytosolic signalling cascades that decipher these cues and transmit them into the cell and to the nucleus, where these signals imprint specific gene expression programmes. By understanding how this functional flexibility is achieved, we may open doors to new therapeutic approaches that harness this property of T cells.

Similar articles

See all similar articles

Cited by 104 PubMed Central articles

See all "Cited by" articles

References

    1. Genes Dev. 2008 Nov 1;22(21):2980-93 - PubMed
    1. Science. 2010 Oct 22;330(6003):521-5 - PubMed
    1. Nature. 2013 Dec 19;504(7480):446-50 - PubMed
    1. Nature. 2008 May 8;453(7192):236-40 - PubMed
    1. Cell Mol Immunol. 2015 Sep;12(5):533-42 - PubMed

Publication types

Feedback